TrinScreen HIV is a rapid test providing results in less than 12 minutes from a finger stick drop of blood.Īmong Region, North America is expected to be the most lucrative region in the global HIV diagnostics test market, owing to increasing inorganic growth strategies such as partnerships by the key players in the region. For instance, in 2021, MedAcess, a healthcare-focused social finance company set up by the Centers for Disease Control and Prevention (CDC), entered into a partnership with Clinton Health Access Initiative (CHAI), a global health organization, and SD Biosensor, an in-vitro diagnostic company, to significantly increase the access to innovative combined rapid testing for syphilis and HIV. For instance, in 2022, Trinity Biotech plc., a company specialized in the development, manufacturing, and marketing of clinical diagnostic products, received approval for its new HIV screening product, TrinScreen HIV, from the World Health Organization (WHO). The global HIV diagnostics test market is expected to exhibit a CAGR of 9.0% during the forecast period, owing to increasing product approvals by the key players. The agreement between Unitaid, Viatris, and Atomo represents a significant market expansion of HIV self-testing, with commitments to make testing available in 135 eligible countries. For instance, in 2021, Viatris Inc., an American global healthcare company and Atomo Diagnostics Limited, a medical device manufacturer, signed a multi-year agreement with the global health agency, Unitaid, in order to expand its access to HIV self-testing in low- and middle-income countries. Furthermore, key players are indulged in signing agreement with the other manufacturers, in order to increase the access of the HIV testing products.
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |